Trial intelligence / Profile preview

Azithromycin for COPD with chronic productive cough

NL-OMON31487Phase 3Not yet recruiting

Sponsor
Isala
Start
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of azithromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Isala. Primary endpoint: Leicester Cough Questionnaire. Planned start Mar 2008; status: not yet recruiting.

02

Drugs

azithromycin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NL-OMON31487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call